Jubilant Pharmova Ltd. | Mid-cap | Healthcare
₹1,120.20
-0.12%
| Jubilant Pharmova Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 71.9B
Gross Profit 48.8B 67.78%
Operating Income 8.1B 11.19%
Net Income 8.4B 11.63%
EPS (Diluted) ₹52.85

Balance Sheet Metrics

Total Assets 127.6B
Total Liabilities 65.2B
Shareholders Equity 62.4B
Debt to Equity 1.04

Cash Flow Metrics

Operating Cash Flow 8.9B
Free Cash Flow -435.0M

Revenue & Profitability Trend

Jubilant Pharmova Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 71.9B 66.4B 62.2B 60.6B 59.6B
Cost of Goods Sold 23.2B 24.2B 22.2B 17.9B 17.5B
Gross Profit 48.8B 42.2B 40.0B 42.7B 42.1B
Operating Expenses 14.8B 11.4B 10.6B 10.7B 9.3B
Operating Income 8.1B 5.2B 2.3B 8.2B 11.2B
Pre-tax Income 9.8B 1.7B 278.0M 6.3B 8.7B
Income Tax 1.4B 978.0M 927.0M 2.2B 3.0B
Net Income 8.4B 727.0M -649.0M 4.1B 8.4B
EPS (Diluted) ₹52.85 ₹4.86 -₹3.83 ₹26.00 ₹52.48

Income Statement Trend

Jubilant Pharmova Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 35.8B 38.8B 37.6B 35.1B 29.5B
Non-Current Assets 91.8B 76.7B 73.9B 64.8B 59.7B
Total Assets 127.6B 115.5B 111.6B 99.9B 89.2B
Liabilities
Current Liabilities 21.6B 18.9B 17.7B 15.9B 10.5B
Non-Current Liabilities 43.5B 42.4B 39.9B 30.8B 31.3B
Total Liabilities 65.2B 61.3B 57.6B 46.7B 41.8B
Equity
Total Shareholders Equity 62.4B 54.2B 53.9B 53.2B 47.4B

Balance Sheet Composition

Jubilant Pharmova Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 9.8B 1.7B 278.0M 6.3B 12.1B
Operating Cash Flow 8.9B 8.2B 1.1B 6.0B 14.9B
Investing Activities
Capital Expenditures -11.1B -8.9B -8.0B -6.0B -5.1B
Investing Cash Flow 4.5B -6.6B -5.6B -2.1B -7.7B
Financing Activities
Dividends Paid -796.0M -798.0M -801.0M -800.5M -14.8M
Financing Cash Flow -11.6B -1.3B 1.5B 1.6B -13.6B
Free Cash Flow -435.0M 736.0M -1.5B 2.4B 12.6B

Cash Flow Trend

Jubilant Pharmova Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 21.22
Forward P/E 23.24
Price to Book 2.84
Price to Sales 2.46
PEG Ratio 0.02

Profitability Ratios

Profit Margin 11.60%
Operating Margin 12.97%
Return on Equity 14.35%
Return on Assets 4.14%

Financial Health

Current Ratio 1.65
Debt to Equity 43.78
Beta 0.80

Per Share Data

EPS (TTM) ₹52.85
Book Value per Share ₹395.41
Revenue per Share ₹456.70

Financial data is updated regularly. All figures are in the company's reporting currency.